Comprehensive analysis of long non-coding RNAs in human breast cancer clinical subtypes

Oncotarget

Volumn 5, Issue 20, 2014, Pages 9864-9876

  Su, Xiaoping ^a   Malouf, Gabriel G ^b   Chen, Yunxin ^a   Zhang, Jianping ^a   Yao, Hui ^a   Valero, Vicente ^a   Weinstein, John N ^a   Spano, Jean Philippe ^b   Meric Bernstam, Funda ^a   Khayat, David ^b   Esteva, Francisco J ^c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

Breast cancer; Enhancers; Expression profiling; lncRNA; RNA seq

Indexed keywords

CIS ACTING ELEMENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR ALPHA; HISTONE H3; LONG UNTRANSLATED RNA; PROTEIN H3K27AC; PROTEIN HOTAIR; PROTEIN HOTAIRM1; REGULATOR PROTEIN; TRANS ACTING FACTOR; TUMOR PROTEIN; UNCLASSIFIED DRUG; ERBB2 PROTEIN, HUMAN; MESSENGER RNA;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST EPITHELIUM CELL; CANCER PROGNOSIS; CHROMATIN STRUCTURE; CONSENSUS SEQUENCE; GENE CLUSTER; GENE EXPRESSION; HISTONE MODIFICATION; HUMAN; HUMAN CELL; MCF 7 CELL LINE; PROTEIN EXPRESSION; RNA ANALYSIS; BIOSYNTHESIS; BREAST TUMOR; CELL TRANSFORMATION; CLASSIFICATION; FEMALE; GENETICS; METABOLISM; SURVIVAL RATE;

BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE EXPRESSION; HUMANS; MCF-7 CELLS; RECEPTOR, ERBB-2; RNA, LONG NONCODING; RNA, MESSENGER; SURVIVAL RATE;

EID: 84928608163     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2454     Document Type: Article

References (41)

1. Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 2009; 23:1494-1504.
2. Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol 2011; 21:354-61.
3. Crea F, Watahiki A, Quagliata L, Xue H, Pikor L, Parolia A, Wang Y, Lin D, Lam WL, Farrar WL, et al. Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer. Oncotarget 2014; 5:764-74.
4. Shi Y, Lu J, Zhou J, Tan X, He Y, Ding J, Tian Y, Wang L, Wang K. Long non-coding RNA Loc554202 regulates proliferation and migration in breast cancer cells. Biochem Biophys Res Commun 2014; pii: S0006-291X(14)00432-X. doi: 10.1016/j.bbrc.2014.02.144. [Epub ahead of print]
5. Zhuang M, Gao W, Xu J, Wang P, Shu Y. The long non-coding RNA H19-derived miR-675 modulates human gastric cancer cell proliferation by targeting tumor suppressor RUNX1. Biochem Biophys Res Commun 2014; Jan 2. pii: S0006-291X(13)02197-9. doi: 10.1016/j. bbrc.2013.12.126. [Epub ahead of print].
6. Du Z, Fei T, Verhaak RG, Su Z, Zhang Y, Brown M, Chen Y, Liu XS. Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer. Nat Struct Mol Biol 2013; 20:908-13.
7. Polyak K. Heterogeneity in breast cancer. J Clin Invest 2011; 121:3786-8.
8. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, et al. Molecular portraits of human breast tumours. Nature 2000; 406:747-52.
9. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001; 98:10869-74.
10. Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, Vickery T, Davies S, Fauron C, He X, Hu Z, et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol 2009; 27:1160-7.
11. Piao HL, Ma L. Non-coding RNAs as regulators of mammary development and breast cancer. J Mammary Gland Biol Neoplasia 2012; 17:33-42.
12. Ponting CP, Belgard TG. Transcribed dark matter: meaning or myth? Hum Mol Genet 2010; 19:R162-8.
13. Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet 2009; 10:155-9.
14. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010; 464:1071-6.
15. Lu L, Zhu G, Zhang C, Deng Q, Katsaros D, Mayne ST, Risch HA, Mu L, Canuto EM, Gregori G, et al. Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer. Breast Cancer Res Treat 2012; 136:875-83.
16. Orom UA, Shiekhattar R. Long non-coding RNAs and enhancers. Curr Opin Genet Dev 2011; 21:194-8.
17. Orom UA, Shiekhattar R: Noncoding RNAs and enhancers: complications of a long-distance relationship. Trends Genet 2011; 27:433-9.
18. Peppercorn J, Perou CM, Carey LA. Molecular subtypes in breast cancer evaluation and management: divide and conquer. Cancer Invest 2008; 26:1-10.
19. McLean CY, Bristor D, Hiller M, Clarke SL, Schaar BT, Lowe CB, Wenger AM, Bejerano G. GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol 2010; 28:495-501.
20. Guo W, Keckesova Z, Donaher JL, Shibue T, Tischler V, Reinhardt F, Itzkovitz S, Noske A, Zurrer-Hardi U, Bell G, et al. Slug and Sox9 cooperatively determine the mammary stem cell state. Cell 2012; 148:1015-28.
21. Stacey SN, Manolescu A, Sulem P, Thorlacius S, Gudjonsson SA, Jonsson GF, Jakobsdottir M, Bergthorsson JT, Gudmundsson J, Aben KK, et al. Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 2008; 40:703-6.
22. Orom UA, Derrien T, Beringer M, Gumireddy K, Gardini A, Bussotti G, Lai F, Zytnicki M, Notredame C, Huang Q, et al. Long noncoding RNAs with enhancer-like function in human cells. Cell 2010; 143:46-58.
23. Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A, Rinn JL. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev 2011; 25:1915-27.
24. Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H, Guernec G, Martin D, Merkel A, Knowles DG, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 2012; 22:1775-89.
25. Creighton CJ. The molecular profile of luminal B breast cancer. Biologics 2012; 6:289-97.
26. Wu SC, Kallin EM, Zhang Y. Role of H3K27 methylation in the regulation of lncRNA expression. Cell Res 2010; 20:1109-16.
27. Meissner A, Mikkelsen TS, Gu H, Wernig M, Hanna J, Sivachenko A, Zhang X, Bernstein BE, Nusbaum C, Jaffe DB, et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 2008; 454:766-70.
28. Engstrom PG, Suzuki H, Ninomiya N, Akalin A, Sessa L, Lavorgna G, Brozzi A, Luzi L, Tan SL, Yang L, et al. Complex Loci in human and mouse genomes. PLoS Genet 2006; 2:e47.
29. Dinger ME, Pang KC, Mercer TR, Mattick JS. Differentiating protein-coding and noncoding RNA: challenges and ambiguities. PLoS Comput Biol 2008; 4:e1000176.
30. Holland DG, Burleigh A, Git A, Goldgraben MA, Perez- Mancera PA, Chin SF, Hurtado A, Bruna A, Ali HR, Greenwood W, et al. ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium. EMBO Mol Med 2011; 3:167-80.
31. Rouzier R, Rajan R, Wagner P, Hess KR, Gold DL, Stec J, Ayers M, Ross JS, Zhang P, Buchholz TA, et al. Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer. Proc Natl Acad Sci U S A 2005; 102:8315-8320.
32. Zhang X, Lian Z, Padden C, Gerstein MB, Rozowsky J, Snyder M, Gingeras TR, Kapranov P, Weissman SM, Newburger PE. A myelopoiesis-associated regulatory intergenic noncoding RNA transcript within the human HOXA cluster. Blood 2009; 113:2526-34.
33. Kim JH, Sharma A, Dhar SS, Lee SH, Gu B, Chan CH, Lin HK, Lee MG. UTX and MLL4 coordinately regulate transcriptional programs for cell proliferation and invasiveness in breast cancer cells. Cancer Res 2014; 74:1705-17.
34. Kleer CG, Cao Q, Varambally S, Shen R, Ota I, Tomlins SA, Ghosh D, Sewalt RG, Otte AP, Hayes DF, et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci U S A 2003; 100:11606-11.
35. Prensner JR, Iyer MK, Balbin OA, Dhanasekaran SM, Cao Q, Brenner JC, Laxman B, Asangani IA, Grasso CS, Kominsky HD, et al. Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat Biotechnol 2011; 29:742-9.
36. Baquero MT, Lostritto K, Gustavson MD, Bassi KA, Appia F, Camp RL, Molinaro AM, Harris LN, Rimm DL. Evaluation of prognostic and predictive value of microtubule associated protein tau in two independent cohorts. Breast Cancer Res 2011; 13:R85.
37. Hillier LW, Marth GT, Quinlan AR, Dooling D, Fewell G, Barnett D, Fox P, Glasscock JI, Hickenbotham M, Huang W, et al. Whole-genome sequencing and variant discovery in C. elegans. Nat Methods 2008; 5:183-8. doi: 10.1038/nmeth.1179.
38. Anders S, Huber W. Differential expression analysis for sequence count data. Genome Biol 2010; 11:R106.
39. Guttman M, Amit I, Garber M, French C, Lin MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 2009; 458:223-7.
40. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005; 102:15545-50.
41. Efron B, Tibshirani R. On testing the significance of gene sets. Ann Appl Stat 2007; 1:107-129.